Your browser doesn't support javascript.
loading
Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study.
Randon, Giovanni; Nakamura, Yoshiaki; Yaeger, Rona; Lonardi, Sara; Cremolini, Chiara; Elez, Elena; Nichetti, Federico; Ghelardi, Filippo; Nasca, Vincenzo; Bergamo, Francesca; Conca, Veronica; Ros, Javier; Bando, Hideaki; Maddalena, Giulia; Oldani, Simone; Prisciandaro, Michele; Raimondi, Alessandra; Schrock, Alexa B; Agnelli, Luca; Walch, Henry; Yoshino, Takayuki; Pietrantonio, Filippo.
Afiliação
  • Randon G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Nakamura Y; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yaeger R; Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.
  • Lonardi S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cremolini C; Department of Oncology, Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy.
  • Elez E; Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Nichetti F; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Ghelardi F; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Nasca V; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Bergamo F; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Conca V; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Ros J; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Bando H; Department of Oncology, Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy.
  • Maddalena G; Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Oldani S; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Prisciandaro M; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Raimondi A; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Schrock AB; Department of Oncology, Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy.
  • Agnelli L; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Walch H; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Yoshino T; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Clin Cancer Res ; 30(2): 436-443, 2024 01 17.
Article em En | MEDLINE | ID: mdl-37610454

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália País de publicação: Estados Unidos